![]() |
F.D.A. Panel’s Action Could Open Way to Lower-Cost Biologics
The group is expected to recommend approval of a cheaper copy of a special cancer drug, which could lead to generic copies of expensive medications.
![]() More... |
| All times are GMT. The time now is 12:04 PM. |